Ling Xu

机构：Shandong University of Aeronautics, Jinan University, Shanghai University of Traditional Chinese Medicine, Bozhou People's Hospital, Guangdong Polytechnic Normal University, Yueyang Hospital, Anqing City Hospital, The Schwarzman Animal Medical Center, Xi'an Chest Hospital, Anqing Normal University, Nanjing Medical University · ORCID：0000-0002-8144-8063

发表论文 118 篇 · 总被引 1496 次 · h-index 23

代表论文

• Abemaciclib increases the risk of venous thromboembolism in breast cancer: Integrate meta-analysis, pharmacovigilance database analysis, and in vitro validation (2024 · Cancer Treatment Reviews · 被引 20)
• Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations (2024 · The Innovation · 被引 13)
• QiDongNing induces lung cancer cell apoptosis via triggering P53 / DRP1 ‐mediated mitochondrial fission (2024 · Journal of Cellular and Molecular Medicine · 被引 13)
• Efficacy of Chinese Medicine on Postoperative Rehabilitation of Non-small Cell Lung Cancer (NSCLC), a Randomized Controlled Study (2025 · Integrative Cancer Therapies · 被引 10)
• Role of the TME in immune checkpoint blockade resistance of non-small cell lung cancer (2024 · Cancer Drug Resistance · 被引 9)
• Isolate distribution and antifungal susceptibility of Saccharomyces cerevisiae in the national regional medical center of Southwest China for women and children during 2018–2023 (2024 · BMC Microbiology · 被引 9)